These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. Kim EH; Surh YJ Biochem Pharmacol; 2008 Dec; 76(11):1544-53. PubMed ID: 18771658 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer. Fenner MH; Elstner E Expert Opin Investig Drugs; 2005 Jun; 14(6):557-68. PubMed ID: 16004588 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis. Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between peroxisome proliferator activator-receptor (PPAR) and urological cancer]. Yoshimura R; Nakatani T Nihon Rinsho; 2005 Apr; 63(4):672-8. PubMed ID: 15828236 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma. Nickkho-Amiry M; McVey R; Holland C Mol Cancer Res; 2012 Mar; 10(3):441-53. PubMed ID: 22205725 [TBL] [Abstract][Full Text] [Related]
18. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Libby P; Plutzky J Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer. Wang Q; Imam MU; Yida Z; Wang F Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]